A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 5068
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : IVIG
Long Form : intravenous immunoglobulin
No. Year Title Co-occurring Abbreviation
2020 A case of an Infant with SARS-CoV-2 hepatitis early after liver transplantation. POD, SARS-CoV-2
2020 A case of dermatomyositis complicated with pleural effusion and massive ascites. DM, EMG, IVCY
2020 A Case of Guillain-Barre Syndrome Associated With COVID-19. COVID-19, CSF, GBS, SARS-COV-2
2020 A Case of Hepatitis B Virus-related Vasculitic Neuropathy in an Inactive Virus Carrier Treated with Intravenous Immunoglobulin. HBV
2020 A Case of Kawasaki Disease Complicated With Cerebral Salt-Wasting Syndrome. CSWS, FEUA, KD, SIADH
2020 A case report of complement C4B deficiency in a patient with steroid and IVIG-refractory anti-NMDA receptor encephalitis. NMDA
2020 A Neglected and Promising Predictor of Severe Hyperbilirubinemia Due to Hemolysis: Carboxyhemoglobin. COHb, TSB
2020 A Patient with CTLA-4 Haploinsufficiency with Multiple Autoimmune Presentations: A Case Report. CMV, LTT, PHA, PID
2020 A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial. BiPAP, BSC, CPAP, CT, EQ-5D-5L, MCS, PCR, PCS, SOFA
10  2020 A Race Against Time-Changing the Natural History of CRIM Negative Infantile Pompe Disease. CRIM, ERT, IPD, ITI, RUSP
11  2020 A Remarkable Coexistence of Systemic Capillary Leak Syndrome and Diabetes in an 11-Year-Old Boy: A Case Report and Review of the Literature. RSV
12  2020 A Systematic Review and Meta-regression Analysis on the Impact of Increasing IgG Trough Level on Infection Rates in Primary Immunodeficiency Patients on Intravenous IgG Therapy. IgG
13  2020 ABO-incompatible transplantation without conventional induction immunosuppression (IL-2RB or depleting agents). PLEX, POD
14  2020 Acceptable Donor-Specific Antibody Levels Before and After Desensitization Therapy in Living Donor Kidney Transplantation. AMR, DSA, MFI, PP
15  2020 Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. ANE, CSF, GFAP, NFL, PLEX
16  2020 Acute Rejection Following Kidney Transplantation: State-of-the-Art and Future Perspectives. ABMR, KDIGO, SOC
17  2020 Add-on or alone? Inhaled nebulized immunoglobulin reduces upper airway infections: 24 months of real-life experience. INHIG, URTI
18  2020 Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease. AAS, KD
19  2020 Adjuvant rituximab improves sensory ataxia in CIDP-related Sjogren syndrome. CIDP, SS
20  2020 Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection. AOSD, HLH, MAS, PE, SLE
21  2020 Adverse reactions and influencing factors in children with primary immunodeficiencies receiving intravenous immunglobulin replacement. ---
22  2020 Albumin levels as a biomarker for second Intravenous Immunoglobulin (IVIG) treatment in Guillain-Barre syndrome (GBS). GBS
23  2020 AMBAR, an Encouraging Alzheimer's Trial That Raises Questions. AD, AMBAR
24  2020 An Overlapping Case of Miller Fisher Syndrome and the Pharyngeal-Cervical-Brachial Variant of Guillain-Barre Syndrome. ER
25  2020 An Unusual and Rare Presentation of Dermatomyositis Sine Dermatitis Complicated by Neuromyositis. CMAP, DM, DMSD, EMG, SNAP
26  2020 An Unusual Recurrence of Miller Fisher Syndrome: Three Times in Eight Years. MFS
27  2020 Anakinra And Etanercept Combination Treatment in a Child With Severe, Nonresponsive Kawasaki Disease. KD
28  2020 Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review. IL-1, KD
29  2020 Anti-A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital-based cohort study. CI, HA, IRRs
30  2020 Anti-CV2/CRMP5 antibody-associated hemorrhagic leukoencephalomyelitis treated with steroids, intravenous immunoglobulin, plasmapheresis, and cyclophosphamide. CRMP5
31  2020 Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice. CBA, ELISA, HMGCR
32  2020 Anti-platelet antibodies in childhood immune thrombocytopenia: Prevalence and prognostic implications. ITP
33  2020 Antibodies and Immunity During Kawasaki Disease. KD
34  2020 Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype. Caspr1, CIDP, CNTN1, EFNS/PNS, IgG, Nfasc155
35  2020 Antibody-mediated complement activation in pathology and protection. ---
36  2020 Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia. FcgammaR, GP, ITP, OR
37  2020 Are Repeated Cycles of Intravenous Immunoglobulin Justified in Patients With Poorly Responsive Guillain-Barre Syndrome? GBS
38  2020 Ascending Paralysis in a 36-Year-Old Woman With Bipolar Disorder and Recent Aspiration Pneumonia. CSF, GBS
39  2020 Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan. CAAs, CI, KD
40  2020 Association between Alanine Aminotransferase/Aspartate Aminotransferase Ratio (AST/ALT Ratio) and Coronary Artery Injury in Children with Kawasaki Disease. AST, CAA, CAL, KD
41  2020 Association between neutropenia and IgG antineutrophil antibodies in a case of CD40LG deficiency due to two novel mutations. CD40L
42  2020 Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients. CAL, CI, KD, OR, P2RY12
43  2020 Association between primary immunodeficiency and asthma exacerbation in adult asthmatics. IgG, PID
44  2020 Association of small-fiber polyneuropathy with three previously unassociated rare missense SCN9A variants. SFN
45  2020 Association of the IL16 Asn1147Lys polymorphism with intravenous immunoglobulin resistance in Kawasaki disease. GWAS, IL16, KD, nsSNPs, OR
46  2020 Atypical Descending Paralysis in Miller Fisher Syndrome: A Rare Variant of Guillain-Barre Syndrome. CSF, GBS, MFS
47  2020 Autoinflammation in addition to combined immunodeficiency: SLC29A3 gene defect. AR, ccf-mtDNA, HS, IL-8, Nceh1, NLRC4, PFKFB4, PRCA, RS, RTE, SDS
48  2020 Beneficial effects of intravenous immunoglobulin as an add-on therapy to azathioprine for NMO-IgG-seropositive neuromyelitis optica spectrum disorders. ARR, EDSS, NMOSD
49  2020 Bernard-Soulier syndrome or idiopathic thrombocytopenic purpura: A case series. BSS, BT, ITP
50  2020 Biomarkers for the Discrimination of Acute Kawasaki Disease From Infections in Childhood. AUC, CAA, CRP, HNE, KD, ROC
51  2020 BK virus-associated nephropathy in a lung transplant patient: case report and literature review. BKVAN, COPD
52  2020 Blood Mercury Levels in Children with Kawasaki Disease and Disease Outcome. CAL, KD
53  2020 Bortezomib-induced motor neuropathy: A case report. ---
54  2020 Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV. RSV
55  2020 CANOMAD syndrome with respiratory failure. ---
56  2020 CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell targeted therapies. ---
57  2020 Catastrophic antiphospholipid syndrome refractory to high-dose intravenous immunoglobulin responsive to therapeutic plasma exchange. APS, CAPS, TPE
58  2020 Childhood-onset multifocal motor neuropathy with IgM antibodies to GM2 and GalNac-GD1a. EFNS/PNS, IgM, MMN
59  2020 Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach. CCS, CIDP, PE
60  2020 Clinical and Molecular Phenotyping in Scleromyxedema Pretreatment and Posttreatment With Intravenous Immunoglobulin. SMX, TGF-beta
61  2020 Clinical Characteristic Analysis of Seven Children With Bickerstaff Brainstem Encephalitis in China. BBE, CSF, EEG, EMG, MRI
62  2020 Clinical characteristics of patients double positive for CASPR2 and LGI1-antibodies. CSF, EMG, MRI
63  2020 Clinical factors influencing the response to intravenous immunoglobulin treatment in cases of treatment-resistant pyoderma gangrenosum. PG
64  2020 Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study. KD
65  2020 Clinical observation of noncoronary cardiac abnormalities in Chinese children with Kawasaki disease. CAA, ECG, KD, NCA, WBC
66  2020 Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study. IVMP
67  2020 Comparison of the Clinical Outcomes of Guillain Barre Syndrome Based on Electrophysiological Subtypes in Pakistani Children. AIDP, AMSAN, GBS, ICU, IRB
68  2020 Complete Regression of Giant Aneurysms in an Infant with Delayed Diagnosis and Refractory Kawasaki Disease via Combination Anticytokine Therapy: Case Report and Review of Similar Cases. KD
69  2020 Concurrent anti-PM-Scl antibody-associated systemic sclerosis and inclusion body myositis - report of two cases and review of the literature. IBM
70  2020 Coronary spastic angina after the administration of intravenous immunoglobulin in myasthenia gravis: a case report. CSA, ECG, MG
71  2020 Correlation between immunoglobulin dose administered and plasma neutralization of streptococcal superantigens in patients with necrotizing soft tissue infections. ---
72  2020 Correlations Among Subcutaneous Immunoglobulin Dosage, ImmunoglobulinG Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies. BMI, IgG, PAD, SCIG
73  2020 Corticosteroid-sparing benefit of intravenous immunoglobulin in systemic sclerosis-associated myopathy: A comparative study in 52 patients. CS, IQR, SSc
74  2020 Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? ---
75  2020 COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid. AIDP, AMAN, AMSAN, CSF, GBS, MFS
76  2020 COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature. ITP
77  2020 COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2). COVID-19, SARS-CoV-2, WHO
78  2020 COVID-19-associated meningoencephalitis treated with intravenous immunoglobulin. CNS, CSF, EEG, ICU
79  2020 Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins. MERS-CoV, SARS-CoV-2
80  2020 Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease. KD
81  2020 Current understanding and unknown aspects of the treatment of granulomatosis with polyangiitis (Wegener's granulomatosis): Opportunities for future studies. ANCA, CYP, GPA, PR3, RTX
82  2020 Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens. SARS-CoV-2
83  2020 Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. ---
84  2020 Cytomegalovirus Humoral Response Against Epithelial Cell Entry-Mediated Infection in the Primary Infection Setting After Hematopoietic Cell Transplantation. CMV, HCT, NAbs, PC, PCR
85  2020 Daily grip strength response to intravenous immunoglobulin in chronic immune neuropathies. CINs
86  2020 Defects of CTLA-4 Are Associated with Regulatory T Cells in Myasthenia Gravis Implicated by Intravenous Immunoglobulin Therapy. DCs, MG, QMG, Treg
87  2020 Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease. CAAs, KD
88  2020 Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin. CAAs, zMax
89  2020 Determination of the Relationship Between Kobayashi, Sano, and Egami Criteria and Prevalence of Intravenous Immunoglobulin Resistance and Coronary Artery Aneurysm in Iranian Children with Kawasaki Disease. CALs, CRP, KD
90  2020 Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity. AAV, NAbs
91  2020 Development of pure red cell aplasia by transmission and persistent infection of parvovirus B19 through a kidney allograft. PCR, PRCA, PVB19
92  2020 Diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy in clinical practice: A survey among Dutch neurologists. CIDP, EFNS/PNS
93  2020 Diagnosis and treatment of Guillain-Barre Syndrome in childhood and adolescence: An evidence- and consensus-based guideline. A-CIDP, GBS, GNP
94  2020 Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. KD, MAS, MIS-C
95  2020 Do cytokines correlate with refractory Kawasaki disease in children? CRP, ESR, IFN-gamma, IL-10, IL-2, IL-4, IL-6, KD, ROC curve, TNF-alpha, WBC
96  2020 Do microdeletions lead to immune deficiency? TRPS2
97  2020 Dramatic clinical response to ultra-high dose IVIg in otherwise treatment resistant inflammatory neuropathies. CIDP, MMNCB
98  2020 Dyshidrotic eczema and seborrheic dermatitis-like eczematous eruption following intravenous immunoglobulin therapy. ---
99  2020 Effect of different doses of aspirin on the prognosis of Kawasaki disease. CAAs, KD
100  2020 Effect of intravenous immunoglobulin (IVIg) on primate complement-dependent cytotoxicity of genetically engineered pig cells: relevance to clinical xenotransplantation. GTKO, HS, RBCs, TKO, WT